Ultima-FTTP 2mg-USA

Ultima-FTTP, 2 mg

Ultima-FTTP 2 mg contains FTTP (Fat-Targeted Proapoptotic Peptide), also known as Adipotide. It is an experimental peptide researched primarily for fat-loss and body-composition applications. Unlike appetite-focused compounds, FTTP has been investigated for its ability to target the vasculature associated with adipose tissue.

How it works

FTTP was designed to target prohibitin-associated pathways in the blood vessels supplying adipose tissue. Its peptide structure includes a targeting sequence linked to a proapoptotic component, allowing researchers to investigate selective effects on fat-associated vascular tissue.

This mechanism makes FTTP particularly interesting for research into adipose-tissue reduction, stubborn fat, body composition, and targeted fat-loss pathways.

Proper Use and Dosage

The listed product contains 2 mg (2,000 mcg) per vial.

Preclinical research and published experimental materials have explored FTTP using body-weight-based dosing, with one commonly cited research protocol using 50 mcg/kg.

For the 2 mg presentation:

• 50 mcg = 40 administrations
• 100 mcg = 20 administrations
• 200 mcg = 10 administrations
• 250 mcg = 8 administrations
• 500 mcg = 4 administrations
• 1 mg = 2 administrations
• 2 mg = 1 full vial

Because FTTP remains an experimental compound, the appropriate research amount depends on the study design, body weight, and formulation.

Benefits

Ultima-FTTP is particularly suited to research involving fat loss, adipose-tissue biology, body composition, and targeted metabolic pathways.

Key benefits and areas of interest include:

• Supports fat-loss research
• Investigated for adipose-tissue targeting
• Supports research into visceral and subcutaneous fat
• Studied for adipose vascular pathways
• Investigated for body-composition changes
• Works through a mechanism distinct from appetite suppressants
• Relevant to stubborn-fat research
• Supports research into programmed cell-death pathways
• Provides a concentrated 2 mg presentation

Its unique targeting mechanism makes FTTP particularly interesting for advanced research into how adipose tissue can be selectively targeted rather than simply reducing appetite or increasing general metabolic activity.

Side Effects

Because FTTP has primarily been investigated in preclinical models, human safety information remains limited. Experimental studies have raised concerns involving kidney-related effects and systemic toxicity, making the compound substantially less characterized than established fat-loss medications.

Where to buy 

Whenever bodybuilders want to buy steroids online, it’s always expected that the steroids shop they buy from – Core Anabolic, for example – has the products they desire. And luckily, Core Anabolic has Ultima-FTTP, 2 mg in stock.